CRDF
Cardiff Oncology Inc
1.30$
-2.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -32.6% | +102.9% | +1,022.4% | +132.8% | +6.4% | +147.2% | -38.5% | -72.0% | +15.4% | -7.7% | +929.5% | +11.0% | -22.3% | -29.7% | +19.1% | -36.3% | |
| – | – | – | -56.2% | +195.8% | +1,184.8% | +140.9% | +4.7% | +150.5% | -43.0% | -75.7% | +34.8% | -11.1% | +1,074.6% | +9.6% | -23.8% | -30.4% | +22.8% | -36.7% | |
| – | – | – | -89.3% | +1,093.1% | +1,444.9% | +138.8% | +5.6% | +147.3% | -43.9% | -78.3% | +39.2% | -11.0% | +1,184.7% | -90.9% | +36.9% | +32.5% | +137.7% | -66.1% | |
| – | – | – | -89.3% | +1,093.1% | +1,444.9% | +138.8% | +5.6% | +147.3% | -43.9% | -78.3% | +39.2% | -11.0% | +1,184.7% | +7.5% | -25.2% | -28.9% | +22.6% | -36.5% | |
| – | – | – | +150.0% | +32.2% | +69.8% | -53.1% | -28.2% | +74.6% | +1.0% | -22.9% | +117.6% | +21.3% | +57.3% | +67.2% | +44.1% | -62.6% | +168.4% | -76.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +12.0% | +220.2% | +42.2% | -36.6% | -46.2% | -32.7% | -28.9% | -38.8% | +232.2% | – | – | – | |
| – | – | – | +21.0% | -4.3% | +80.2% | -28.8% | +203.8% | +10.7% | +6.3% | -76.1% | -29.3% | +41.3% | +13.7% | +38.9% | +7.9% | +20.8% | +19.7% | +15.8% | |
| – | – | – | +6.6% | -58.2% | -48.9% | +175.2% | +123.5% | +82.7% | -4.9% | -49.4% | -24.9% | +61.3% | +28.0% | +7.2% | +19.0% | +33.7% | +28.6% | +22.1% | |
| – | – | – | +10.7% | – | – | – | +858.3% | +175.2% | -54.8% | -43.6% | – | – | -0.6% | -35.9% | +22.5% | +2.4% | +2.7% | +2.8% | |
| – | – | – | -22.8% | +45.5% | -81.1% | +63.1% | +803.7% | -59.8% | +8.6% | -27.0% | -19.4% | -1.3% | +108.1% | +5.3% | +35.9% | +0.5% | +145.2% | +67.7% | |
| – | – | – | – | – | – | – | – | – | +26.1% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +840.2% | -59.1% | +483.3% | -59.4% | -67.1% | +55.0% | -27.5% | +1,652.9% | +9.6% | -24.3% | -34.4% | +18.9% | -45.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -92.9% | -93.3% | +42.0% | +35.7% | +34.6% | +29.9% | +12.3% | +38.7% | +14.5% | +14.5% | +383.8% | +156.4% | +249.4% | +87.0% | +11.7% | +2.5% | +6.7% | +40.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.